Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
50Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $567.80M | $153.22M | $2.99 |
| 2024 | $517.42M | $151.26M | $3.00 |
| 2023 | $489.64M | $129.05M | $2.62 |
| 2022 | $573.72M | $171.04M | $3.51 |
| 2021 | $583.83M | $211.40M | $4.38 |
Social Signal Score
Earnings
Thu, Oct 15(in 2 months)
Consensus estimate $0.89 per share
Typical surprise -0.6% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 16$0.85 vs $0.85miss
- Thu, Apr 16$0.79 vs $0.81miss
- Thu, Jan 22$0.81 vs $0.81beat
- Thu, Oct 16$0.81 vs $0.78beat
- Thu, Jul 17$0.73 vs $0.75miss
- Wed, Apr 16$0.75 vs $0.72beat
Estimates and results for CNS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CNS's reported EPS growth of -9.1% a year over 4 years.
- EPS in 5 years
- $1.86
- Implied price
- $38.97
- Return from $84.74
- -14.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $19.37 — -77.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 15 | 18 | 21 | 24 | 27 |
|---|---|---|---|---|---|
| -19.1% | -28.8% | -26.1% | -23.8% | -21.7% | -19.9% |
| -14.1% | -24.4% | -21.6% | -19.1% | -16.9% | -14.9% |
| -9.1% | -20.0% | -17.0% | -14.4% | -12.1% | -10.0% |
| -4.1% | -15.6% | -12.4% | -9.7% | -7.2% | -5.0% |
| 0.9% | -11.2% | -7.9% | -5.0% | -2.4% | -0.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (4)
- Newsprnewswire.com·23h ago·Neutral
Cohen & Steers Announces Changes to Realty Indexes NEW YORK, Aug. 14, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio Index (IRP), effective as of the close of business on August 21, 2026. Cohen & Steers Realty Majors Portfolio Index (RMP) Added component (symbol) Removed component (symbol) CareTrust REIT Inc. (CTRE) Cohen & Steers Global Realty Majors Portfolio Index…
View source ↗ - Newsprnewswire.com·3d ago·Neutral
Cohen & Steers Launches Real Assets Active ETF (CSRA) NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today announced it has launched the Cohen & Steers Real Assets Active ETF (CSRA). This ETF harnesses the firm's four decades of leadership in listed real assets to offer an actively managed, diversified solution investing across real estate, infrastructure, natural resources and commodities.
View source ↗ - Newsaccessnewswire.com·3d ago·Neutral
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation Company reports approximately $20.0 million cash position and extended operating runway following oversubscribed $22.5 million financing, as it advances its pivot toward a diversified, high-value pipeline HOUSTON, TX / ACCESS Newswire / August 12, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focu
View source ↗ - Newsprnewswire.com·4d ago·Neutral
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for July 2026 NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $102.5 billion at July 31, 2026, an increase of $2.4 billion from assets under management of $100.1 billion at June 30, 2026. The increase was due to market appreciation of $1.9 billion and net inflows of $688 million, partially offset by distributions of $155 million.
View source ↗